UK Markets close in 3 hrs 17 mins

Walgreens Boots Alliance, Inc. (WBA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
48.09-0.06 (-0.12%)
At close: 4:00PM EST

47.91 -0.18 (-0.37%)
Before hours: 8:11AM EST

Full screen
Trade prices are not sourced from all markets
Previous close48.15
Bid48.00 x 1100
Ask48.15 x 2900
Day's range47.06 - 48.17
52-week range33.36 - 54.53
Avg. volume8,230,543
Market cap41.552B
Beta (5Y monthly)0.54
PE ratio (TTM)N/A
EPS (TTM)-0.80
Earnings date31 Mar 2021 - 05 Apr 2021
Forward dividend & yield1.87 (3.89%)
Ex-dividend date18 Nov 2020
1y target est45.33
  • Walgreens Boots Alliance to Webcast Virtual Annual Meeting of Stockholders
    Business Wire

    Walgreens Boots Alliance to Webcast Virtual Annual Meeting of Stockholders

    Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will hold its virtual annual stockholders’ meeting on Jan. 28, 2021 at 8:00 a.m. CST.

  • Walgreens Statement in Support of President-Elect Biden’s COVID-19 Update
    Business Wire

    Walgreens Statement in Support of President-Elect Biden’s COVID-19 Update

    Following President-elect Joe Biden’s COVID-19 Update, Walgreens issued the following statement from John Standley, Walgreens president.

  • Bloomberg

    N.J. Opens Vaccines to 65 and Over, Those With Health Issues

    (Bloomberg) -- New Jersey will expand Covid-19 vaccinations to people 65 years old and over and those ages 16 to 64 who have “health challenges,” Governor Phil Murphy said. The new group includes smokers, those who are obese, and people being treated for cancer, diabetes and kidney and cardiac disorders.New Jersey set a six-month goal of immunizing 4.7 million people, about 70% of the population. The new eligibility means that at least 2 million people will have access to one of two Covid-19 vaccines starting on Thursday, officials said at a Trenton virus update.The U.S. Centers for Disease Control and Prevention on Tuesday had recommended expanding eligibility to high-risk populations. Since Dec. 14, when the doses became available in New Jersey, the state has administered 264,481 doses, or less than 40% of the vaccines distributed. The vaccines until Thursday have been restricted to medical workers, first responders and residents of long-term health-care facilities.Of New Jersey’s 18,070 lab-confirmed novel coronavirus deaths and 2,091 with a probable link, 80% have occurred in the 65-and-over population. Those who smoke and are obese are at increased risk of dying from the disease, as are people with serious conditions.Those seeking vaccinations must have appointments, according to state Health Commissioner Judith Persichilli. People with the following conditions are eligible: obesity, cancer, chronic kidney disease, chronic obstructive pulmonary disease, heart conditions, Down syndrome, sickle-cell disease and type 2 diabetes. Smokers also qualify. The state isn’t requiring documentation of the conditions, Persichilli said.More than 1.2 million people have registered for vaccine appointments, Murphy said, and he urged that the latest group have patience during sign-ups at Jersey Tuesday recorded 6,922 positive test results, a single-day state record, and 95 deaths. Tests run on Jan. 9 showed positivity at 13.53%, which Murphy called too high. The transmission rate, 1.10%, shows the virus is spreading.Regarding vaccine supply on hand versus what’s been administered, Murphy in an earlier interview on CNBC said doses are set aside for CVS Health Corp. and Walgreens Boots Alliance Inc. to give to nursing home residents through January.“It looks like there’s a gap which in fact doesn’t exist,” Murphy said. “These are allocations for visits, for engagements, for appointments that they’ve made already for long-term care facilities.”Still, Murphy on CNBC said the state has “an enormous supply-demand imbalance right now.” He said he was confident that the issue will ease with the incoming Joe Biden administration.(Updates with eligibility starting in first paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.